UK-based engineered antibodies manufacturer Absolute Antibody Ltd has merged with KeraFAST Inc, a life science research company based in the US.

Both companies will retain their names and employees under one combined organisation.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The merger will enhance the global reach of the two companies and enable them to provide custom services to their customers.

Charles River Laboratories International Inc has agreed to purchase MPI Research Inc for $800m.

Charles River is a pre-clinical and clinical laboratory services provider, while the MPI offers contract research. Both companies are based in the US.

The acquisition is scheduled to complete in Q2 2018 and will help Charles River enter growing end markets and scale-up production to meet demand.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Charles River appointed Morgan Stanley & Co LLC as financial advisor, and Davis Polk & Wardwell LLP as legal advisor for the transaction. Jefferies LLC and SunTrust Robinson Humphrey Inc were appointed as financial advisors, and Weil, Gotshal & Manges LLP as legal advisor to MPI.

“The acquisition is scheduled to complete in Q2 2018 and will help Charles River enter growing end markets and scale-up production to meet demand.”

SGS SA has acquired Skin Investigation and Technology Hamburg GmbH (SIT).

SGS provides inspection, verification and testing services, while SIT is a dermatological contract research organisation (CRO). Both companies are based in Germany.

The acquisition will expand SGS’s consumer and retail service portfolio.

Zhejiang Starry Pharmaceutical Co Ltd plans to acquire Zhejiang Hisyn Pharmaceutical Co Ltd in a cash and share issue deal.

Based in China, Zhejiang Starry Pharmaceutical is a pharmaceutical raw materials and intermediates manufacturer.

Citigroup Securities Co Ltd has been appointed as the financial advisor, while Jincheng, Tongda & Neal is the legal advisor for the transaction by the acquirer company.

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact